Pharma Ag Novartis, 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 2,451 shares at $2.62 ($6K) on 2009-05-29, disclosed to the SEC on 2009-05-29.
Open-market purchase of $6k IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| IDIX | BUY | 2011-12-09 | $115K | — | Filing → |
| IDIX | BUY | 2011-11-22 | $206K | — | Filing → |
| IDIX | BUY | 2010-11-26 | $47K | — | Filing → |